P38 Mitogen-Activated Protein Kinase Inhibition Ameliorates Angiotensin II-Induced Target Organ Damage

Hypertension - United States
doi 10.1161/01.hyp.0000256831.33459.ea
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Chronic P38 Mitogen-Activated Protein Kinase Inhibition Improves Vascular Function and Remodeling in Angiotensin II-dependent Hypertension

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2016English

P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14)

Science-Business eXchange
2014English

P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14)

Science-Business eXchange
2012English

P38 Mitogen-Activated Protein Kinase in Beryllium-Induced Dendritic Cell Activation

Human Immunology
MedicineAllergyImmunology
2014English

Angiotensin II-Induced Hypertension : Contribution of Ras GTPase/Mitogen-Activated Protein Kinase and Cytochrome P450 Metabolites

Hypertension
Internal Medicine
2000English

Catechins Inhibit Angiotensin II-induced Vascular Smooth Muscle Cell Proliferation via Mitogen-Activated Protein Kinase Pathway

Experimental & Molecular Medicine
2006English

P38 Mitogen-Activated Protein Kinase (P38 MAPK; MAPK14); X-Box Binding Protein 1 (XBP1)

Science-Business eXchange
2011English

Cutaneous P38 Mitogen-Activated Protein Kinase Activation Triggers Psoriatic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Inhibition of P38 Mitogen-Activated Protein Kinase Reduces Inflammation After Coronary Vascular Injury in Humans

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy